REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 14th, 2003 • Hollis Eden Pharmaceuticals Inc /De/ • Pharmaceutical preparations • New York
This Registration Rights Agreement (this “Agreement”) is made and entered into as of February 25, 2003, among Hollis-Eden Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the purchasers signatory hereto (each such purchaser is a “Purchaser” and all such purchasers are, collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 14th, 2003 • Hollis Eden Pharmaceuticals Inc /De/ • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of February 25, 2003, among Hollis-Eden Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the purchasers identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
STOCK PURCHASE WARRANT To Purchase Shares of Common Stock of Hollis-Eden Pharmaceuticals, Inc.Stock Purchase • March 14th, 2003 • Hollis Eden Pharmaceuticals Inc /De/ • Pharmaceutical preparations
THIS STOCK PURCHASE WARRANT CERTIFIES that, for value received, (the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after February 25, 2003 (the “Initial Exercise Date”) and on or prior to the close of business on the fourth anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Hollis-Eden Pharmaceuticals, Inc., a corporation incorporated in the State of Delaware (the “Company”), up to shares (the “Warrant Shares”) of Common Stock, par value $0.001 per share, of the Company (the “Common Stock”). The purchase price of one share of Common Stock (the “Exercise Price”) under this Warrant shall be $ [$6.17/$6.71], subject to adjustment hereunder. The Exercise Price and the number of Warrant Shares for which the Warrant is exercisable shall be subject to adjustment as provided herein. Capitalized terms used and not otherwise defined
NEITHER THESE SECURITIES NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER...Hollis Eden Pharmaceuticals Inc /De/ • March 14th, 2003 • Pharmaceutical preparations
THIS DEBENTURE is one of a series of duly authorized and issued debentures of Hollis-Eden Pharmaceuticals, Inc., a Delaware corporation, having a principal place of business at 4435 Eastgate Mall, Suite 400, San Diego, CA 92121(the “Company”), designated as its 7.5% Convertible Debentures, due February 25, 2006 in the aggregate principal amount of $10,000,000 (the “Debentures”).
